Metabolomics Applications in Precision Medicine: An Oncological Perspective

Area of Science:

• Oncology
• Biochemistry
• Systems Biology

Background:

• Conventional cancer therapy often uses a one-size-fits-all approach, limiting treatment efficacy.
• Current treatment decisions based on clinical stage overlook individual patient biology and malignancy drivers.
• Lack of data on specific biochemical signatures hinders the development of targeted cancer therapies.

Purpose of the Study:

• To review the applications of metabolomics in oncology.
• To highlight the potential of metabolomics for advancing precision medicine in cancer care.
• To discuss how metabolomics can identify novel biomarkers for cancer diagnosis and treatment.

Main Methods:

• Review of existing literature on metabolomics in oncological processes.
• Analysis of how metabolomics identifies changes in metabolite expression and biochemical pathways.
• Discussion of metabolomics' role in characterizing metabolic subtypes and patient-specific data.

Main Results:

• Metabolomics provides a deeper understanding of cancer by revealing alterations in bioenergetic metabolism.
• Identifies changes in metabolite patterns and concentrations, offering insights beyond individual metabolites.
• Reveals alterations in biochemical pathways crucial for understanding cancer progression.

Conclusions:

• Metabolomics holds significant potential for identifying novel biomarkers in cancer.
• Applications include developing specific diagnostic methods, monitoring treatment response, and evaluating prognosis.
• This omics approach is key to advancing precision medicine in oncology by enabling personalized treatment strategies.